Zinc deficiency affects nearly 2 billion people in the developing world resulting in growth retardation, hypogonadism, immune dysfunction and cognitive impairment. Additionally, the roles of this divalent cation in the human body have not been clearly elucidated, since the essentiality of zinc has only been known within the last 50 years. However, it has been clearly documented that the supplementation of zinc improves many conditions such as; acute diarrhea in children, the common cold, infections in the elderly, oxidative stress and generation of inflammatory cytokines. Janet Ludwig, Ph.D. has worked in this area of study specifically modifying cellular injury by zinc supplementation.
This presentation from a webinar in May 2012 explore the following areas in order to begin to understand the therapeutic role of zinc in many inflammatory conditions:
• Zinc roles in the body-metalloenzymes
• Zinc as an antioxidant and anti-inflammatory agent
• Membrane stabilization by zinc
• Inflammatory diseases ameliorated by zinc supplementation.
Janet Ludwig, PhD has worked in the area of zinc and inflammation for more than 25 years. She was at the Division of Surgical Biology at the Arizona Health Sciences Center studying zinc and cell injury induced by alcohol and carbon tetrachloride, an effective hepatotoxin. Additionally, she studied the mechanisms and structural identification of the potent class of inflammatory mediators, Platelet-Activating Factors (PAFs), at the Department of Pathology, University of Texas Health Sciences Center in San Antonio. She has taught courses in inflammation, biochemistry and nutrition at various Universities. She also travels to Bangkok, Thailand to give nutritional advice in a non-governmental organization that aids in improving the conditions for impoverished women and their children. Currently she is on the Hawthorn University faculty.